Søgning på udtrykket 'dengue' giver 46 resultater


Dokumenter [1] Sider [2] Kalender [3] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [1]

Sider [2]

…e behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Congo, Rift Valley virus o.a. forekommer endemisk og epidemisk, og giver vedvarende anledning til at disse sygdomme kan importeres til Danmark. Senest har der været fokus på mulig bioterrorisme med f.eks. kopper eller miltbrand. Udredni…

…e behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Congo, Rift Valley virus o.a. forekommer endemisk og epidemisk, og giver vedvarende anledning til at disse sygdomme kan importeres til Danmark. Senest har der været fokus på mulig bioterrorisme med f.eks. kopper eller miltbrand. Udredni…


Kalender [3]

8. marts 2016, Kommunehospitalet, København
10. august 2015, Havana, Cuba

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
18.05.2024
. Abstract. . Background. Dengue Viral Infection (DVI) has become endemic in Pakistan since the first major outbreak in Karachi in 1996. Despite aggressive measures taken by relevant authorities, Pakistan has been dealing with a worsening dengue crisis for the past two decades. DHF is severe form of dengue infection which is linked with significant morbidity and mortality. Early identification of severe dengue infections can…
Lancet Microbe
16.05.2024
Our results demonstrated the potential of Wolbachia-mediated incompatible insect technique for strengthening dengue control in tropical cities, where dengue burden is the greatest.
Trends in Microbiology
15.05.2024
Dengue is a mosquito-borne viral disease which causes significant morbidity and mortality each year. Previous research has proposed several mechanisms of pathogenicity that mainly involve the dengue virus and host humoral immunity. However, innate immune cells, such as neutrophils, may also play an important role in dengue, albeit a much less defined role. In this review, we discuss the emerging roles of neutrophils in dengue and their involvement in pathologies associated with severe dengue. We also descri…
Science
10.05.2024
Science, Volume 384, Issue 6696, Page 639-646, May 2024.
The Lancet Microbe
8.05.2024
Our results demonstrated the potential of Wolbachia-mediated incompatible insect technique for strengthening dengue control in tropical cities, where dengue burden is the greatest.
BMC Infectious Diseases
3.05.2024
… control of the infection. The footprint of Aedes and the diseases it carries have spread relentlessly despite massive volumes of temephos. Recent advances in community participation show this might be more effective and sustainable for the control of the dengue vector. . . . Methods. Using data from the Camino Verde cluster randomized controlled trial, a compartmental mathematical model examines the dynamics of dengue infe…
PLoS One Infectious Diseases
3.05.2024
by Ikkoh Yasuda, Nobuo Saito, Motoi Suzuki, Dorcas Valencia Umipig, Rontgene M. Solante, Ferdinand De Guzman, Ana Ria Sayo, Michio Yasunami, Nobuo Koizumi, Emi Kitashoji, Kentaro Sakashita, Chris Fook Sheng Ng, Chris Smith, Koya Ariyoshi .
Journal of Infectious Diseases
2.05.2024
Abstract . Background . We explored the impact of prior Yellow fever (YF) or Japanese encephalitis (JE) vaccination on the efficacy of Takeda’s dengue vaccine candidate, TAK-003 (NCT02747927).Methods . Children 4–16 years of age were randomized 2:1 to receive TAK-003 or placebo and were under active febrile surveillance. Symptomatic dengue was confirmed by serotype-specific RT-PCR. YF and JE vaccination history was recorded.Results . Of the 20,071 children who received TAK-003 or placebo, 21.1% had a YF…
American Journal of Tropical Medicine and Hygiene
2.05.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 5 Pages: 856-867. .
American Journal of Tropical Medicine and Hygiene
2.05.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 5 Pages: 971-978. .
PLoS One Infectious Diseases
30.04.2024
…hd Desa, Lim Chee Hwa, Sukhvinder Singh Sandhu, Nooreen Farzana Mustapha, Norazman Mohd Rosli, Mohd ‘Ammar Ihsan Ahmad Zamzuri, Mohd Rohaizat Hassan, Nazri Che Dom, Syed Sharizman Syed Abdul Rahim, Balvinder Singh Gill, Nurulhusna Ab Hamid . Background Dengue is a mosquito-borne disease caused by four distinct, closely related dengue viruses (DENV). Global dengue incidence has markedly increased in the past decades. The World Health Organization reported that cases increased from 505,430 in 2000 to 5.2 m…
Journal of Medical Virology
30.04.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
Lancet Infectious Diseases
26.04.2024
Participants who had tetravalent dengue purified inactivated vaccine prime and live-attenuated vaccine boost were unprotected against dengue virus-1 infection and further showed increased clinical, immunological, and transcriptomic evidence for inflammation potentially mediated by pre-existing infection-enhancing antibodies. This study highlights the impact of small cohort, human challenge models studying dengue pathogenesis and downstream vaccine development.
Science
18.04.2024
Science, Volume 384, Issue 6693, Page 260-260, April 2024.
BMC Infectious Diseases
12.04.2024
. Abstract. . Background. Dengue has become an alarming global problem and is endemic in many countries, particularly in tropical and subtropical countries. The aim of this study was to investigate dengue fever outbreak in Banadir Region, Somalia, to understand the risk factors (time, place, personal characteristics). . . . Methods. A descri…
PLoS One Infectious Diseases
4.04.2024
by Rajendra Prasad Chatterjee, Aroni Chatterjee, Sabbir Ansari, Shilpa Chatterjee, Shyamalendu Chatterjee, Nilanjan Chakraborty . Dengue and chikungunya are co-circulating vector-borne diseases that share a significant number of clinical symptoms. To identify variables to aid physicians in making rapid and effective diagnostic decisions, we performed molecular diagnosis of the chikungunya virus and examined the clinical manifestations of chikungunya cases to identify the prevalence among dengue-negative in…
American Journal of Tropical Medicine and Hygiene
3.04.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 4 Pages: 731-737. .
American Journal of Tropical Medicine and Hygiene
3.04.2024
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 110 Issue: 4 Pages: 738-740. .
Antimicrobial Agents And Chemotherapy
26.03.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Lancet Infectious Diseases
23.03.2024
The risk of developing virologically confirmed dengue after a single dose of CYD-TDV varied by baseline DENV serostatus. Since the study assessed the effect of only a single dose, the findings cannot inform decisions on vaccination by public health officers. However, the findings have implications for children who receive an incomplete vaccination regimen and these results should prompt more detailed analyses in future trials on dengue vaccines.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
18.05.2024
The World Health Organization (WHO) said on Wednesday that it had cleared Takeda Pharmaceuticals' dengue vaccine, giving international procurement agencies another option. . Reuters Health Information
Medscape Infectious Diseases
19.04.2024
Dengue cases have created an 'emergency situation' in the Americas, although cases in hotspots Argentina and Brazil appear to have stabilized, the head of the Pan American. . Reuters Health Information
Medscape Infectious Diseases
18.04.2024
It is important to inform patients about warning signs such as abdominal pain, repeated vomiting, decreased urine output, or dizziness when standing, says an epidemiologist. . Medscape Infectious Diseases
Medscape Infectious Diseases
12.04.2024
The vaccine should be used alongside measures such as vector control, prevention, and education, according to the organization. . Medscape Medical News
Medscape Infectious Diseases
11.04.2024
A perfect storm of epidemiologic factors is exacerbating the spread of dengue in Brazil and throughout the world. . Medscape Emergency Medicine
Eurosurveillance latest updates
5.04.2024
In February 2023, German public health authorities reported two dengue cases (one confirmed, one probable) and four possible cases who travelled to Ibiza, Spain, in late summer/autumn 2022; the infection was probably acquired through mosquito bites. Case 1 visited Ibiza over 1 week in late August with two familial companions; all three developed symptoms the day after returning home. Only Case 1 was tested; dengue virus (DENV) infection was confirmed by presence of NS1 antigen and IgM antibodies. Case 2 tra…
Medscape Infectious Diseases
29.03.2024
Dengue cases in the Americas rose in the first three months of this year by three times the number of infections reported in the same period last year, the head of the Pan. . Reuters Health Information
Medscape Infectious Diseases
22.03.2024
A major outbreak in Argentina of dengue, a mosquito-borne illness that can be fatal, is on track to smash previous records, reflecting wider worry around South America where. . Reuters Health Information
Medscape Infectious Diseases
7.03.2024
Drones fly high above Sao Paulo in search of mosquito-ridden puddles in an effort to tackle the spike in dengue cases around Brazil, as experts say current vaccine supplies. . Reuters Health Information
Eurosurveillance latest updates
2.02.2024
Dengue virus (DENV) infections after exposure in Egypt increased in Germany in 2023, with 36 cases vs zero to eight in 2017 to 2022. Over 90% of the patients had stayed on the Red Sea Coast (mostly Hurghada), almost 50% in private residences. Case numbers increased more strongly than traveller numbers. Mosquito control is more difficult in towns than hotel grounds, increasing the risk of infection at private residences. Physicians should consider dengue for unexplained fever after return from Egypt. .
Morbidity and Mortality Weekly Report (MMWR)
2.02.2024
This report describes an increase in dengue cases in Peru during 2023.
Medscape Infectious Diseases
26.01.2024
South America is seeing a surge in cases of the mosquito-borne disease dengue during the southern hemisphere summer, prompting Brazil to roll out a novel vaccine campaign,. . Reuters Health Information
Emergencies and Outbreaks from The Who Regional Office for Africa
20.01.2024
. Dengue . elombatd@who.int . Sat, 20/01/2024 - 18:12. Read more about Dengue. Dengue fever is an arbovirus transmitted by Aedes mosquitoes (both Ae. aegypti and Ae. albopiticus). It is a severe, flu-like illness that affects infants, young children and adults, but seldom causes death. .
Eurosurveillance latest updates
8.12.2023
A cluster of three confirmed autochthonous dengue cases was detected in October 2023 in the Val-de-Marne department neighbouring Paris, France. This marks the northernmost transmission of dengue in Europe reported to date. The epidemiological and microbiological investigations and the vector control measures are described. This event confirms the need for early case detection and response to contain dengue in Europe, especially given the 2024 Summer Olympic and Paralympic Games, when millions of visitors wi…
Eurosurveillance latest updates
3.11.2023
Between August and September 2023, three distinct autochthonous dengue virus transmission events occurred in Lazio, Italy, with the main event in Rome. The events involved three different dengue serotypes. No link with previous imported cases was identified. Here we describe the epidemiological and phylogenetic analysis of the first autochthonous cases and the implemented control actions. The multiple transmission events call for a strengthening of the vector control strategies and future research to better…
Eurosurveillance latest updates
15.09.2023
In August 2023, six locally acquired dengue virus 1 infections were detected in Lodi province, Lombardy Region, in northern Italy, where the vector Aedes albopictus is present. Four cases were hospitalised, none died. The viruses clustered with Peruvian and Brazilian strains collected between 2021 and 2023. This preliminary report highlights the importance of continued integrated surveillance of imported vector-borne virus infections and the potential for tropical disease outbreaks in highly populated regio…
Morbidity and Mortality Weekly Report (MMWR)
31.07.2023
This report describes an increase in travel-associated dengue cases in the U.S. in 2019 compared to 2010-2018 and 2020-2021.
Eurosurveillance latest updates
21.07.2023
. Background. After 40 years of limited viral circulation, Reunion Island has since 2018 experienced recurrent dengue outbreaks of increasing intensity and severity. . . Aim. We aimed to report on the epidemiology and characteristics of dengue in Reunion Island between 2018 and 2021. . . Methods. Between 2018 and August 2021, we systematically collected data on dengue cases via an automated transmission system between the health authorities and the medical laboratories. We set up additional surveillan…
ECDC Epidemiological Update
19.06.2023
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
Morbidity and Mortality Weekly Report (MMWR)
17.05.2023
CDC presents findings reported to CDC through ArboNet, a national arboviral surveillance system, on cases of dengue in U.S. Territories during 2010-2020.

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.4
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.784 s

Cookies og privatliv